A fast, cost effective, NHS led service providing independent analysis of explanted medical devices.
Explant analysis available at a previously unattainable price point.
Developments in automation, processes innovation and creation of validated, peer reviewed analysis methods have enabled us to now make explant analysis available at a previously unattainable price point.
Our service enables surgeons and hospitals to access a fast, cost effective analysis service that can provide expert explant reports and even provide completed MHRA Yellow Cards for adverse event submission to national reporting authorities.


‘The Medicines Healthcare products Regulatory Agency (MHRA) is actively involved in discussions and supports the development of implant explant centres. Benefits of implant explant centres include the potential for earlier detection of safety signals relating to medical devices which contributes to improving patient safety. We are keen to ensure that all adverse events identified are reported to the MHRA via the Yellow Card scheme for England and Wales or through national reporting authorities in Scotland and Northern Ireland. Manufacturers hold responsibilities to monitor the safety and performance of their devices. The information in the generated reports can hold rich information to support this. The MHRA would support manufacturers having access to this information and the device post explant for further investigation
SERVICE OPTIONS
The IAS provides two service options:
Single Device Service
This service is recommended when a surgeon either identifies or suspects an issue and wishes to receive a comprehensive explant report including an in-depth analysis with high-resolution imagery, precisely quantifying volumetric wear.
High Volume Service
This highly cost-effective service ensures that all explants from the surgeon, or department, are thoroughly screened and a concise report indicating any potential issues with the device is provided. In cases where an issue is identified the surgeon has the option to upgrade the screening report to a comprehensive report for an additional fee.



